Acorda Therapeutics , Nasdaq: ACOR
Developing drugs for the treatment of multiple sclerosis and spinal cord injuries.
Industry: Health Care
First Day Return: +12.0%
Industry: Health Care
ACOR
Developing drugs for the treatment of multiple sclerosis and spinal cord injuries.
| IPO Data | |
|---|---|
| IPO File Date | 10/05/2005 |
| Offer Price | $6.00 |
| Price Range $11.00 - $13.00 | |
| Offer Shares (mm) | 5.5 |
| Deal Size ($mm) | $33 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 02/09/2006 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $33 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Hawthorne, NY, United States |
| Founded | 1995 |
| Employees at IPO | n/a |
| Website www.acorda.com | |
IPO News for Acorda Therapeutics
Acorda Therapeutics (ACOR) Performance
